Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on May 27, 2026.
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natural Capsules Limited held its Board meeting on May 27, 2026, approving audited financial results for FY 2026. Standalone net profit grew 67% to Rs. 1,121.39 lakhs from Rs. 671.11 lakhs in FY 2025, with revenue from operations at Rs. 17,377 lakhs. The Board re-appointed Mr. Laxminarayan Moondra as Whole-time Director for 3 years (effective July 28, 2026, subject to shareholder approval) and appointed Mr. Akshay Dutta as Company Secretary and Compliance Officer. M/s. Mallya & Mallya was appointed as Internal Auditor. The company also allotted 25,000 equity shares upon exercise of ESOP 2025 options, increasing paid-up capital to Rs. 10,41,11,540. Statutory auditors issued an unmodified opinion on the financial statements.
Strong financial performance with 67% profit growth is positive for shareholders. The ESOP allotment has minimal dilution effect. The Mundra family controls multiple board positions which may raise governance considerations for some investors.